An anodically pretreated boron-doped diamond electrode surface for square-wave adsorptive stripping voltammetric quantification of the non-absorbable antibiotic rifaximin in the pharmaceutical formulation

被引:14
作者
Barzani, Hemn A. H. [1 ,2 ]
Ali, Hoshyar Saadi [1 ,3 ]
Yardim, Yavuz [4 ]
机构
[1] Van Yuzuncu Yil Univ, Fac Sci, Dept Analyt Chem, TR-65080 Van, Turkey
[2] Aynda Private Tech Inst, Dept Pharm, Erbil 44001, Iraq
[3] Knowledge Univ, Coll Sci, Dept Med Lab Sci, Kirkuk Rd, Erbil 44001, Iraq
[4] Van Yuzuncu Yil Univ, Fac Pharm, Dept Analyt Chem, TR-65080 Van, Turkey
关键词
Rifaximin; Voltammetric determination; Boron-doped diamond electrode; Pharmaceutical formulation; RAPID-DETERMINATION; RAT SERUM; LACTULOSE; SENSOR;
D O I
10.1016/j.diamond.2022.109647
中图分类号
T [工业技术];
学科分类号
08 ;
摘要
This study presents an electroanalytical examination with the voltammetric technique for quantitatively evaluating rifaximin (RFX) using the non-modified boron-doped diamond (BDD) electrode. By utilizing cyclic voltammetry (CV) method, RFX illustrated only one well-defined, irreversible, adsorption-controlled by oxidation and reduction peak at about +0.64 V and +0.21 V, respectively, (vs Ag/AgCl) in 0.1 M HNO3 solution. The square-wave (SW) voltammetric technique examined the dependence of potentials and current intensities on the BDD electrode pretreatment, the nature of a supporting electrolyte, pH, and another characteristic. When the SW mode was used, a satisfactory linear response was achieved in 0.1 M HNO3 solution at +0.56 V (vs Ag/AgCl). The dynamic range is observed from 0.5 to 20.0 mu g mL-1 (6.36 x 10-7-2.54 x 10- 5 M) via a low limit of detection of 0.14 mu g mL-1 (1.7810-7 M). The applicability of the developed method for detecting RFX was exhibited in pharmaceutical formulation samples.
引用
收藏
页数:9
相关论文
共 46 条
[21]   Analytical Applications of Electrochemically Pretreated Boron-Doped Diamond Electrodes [J].
Lourencao, Bruna C. ;
Brocenschi, Ricardo F. ;
Medeiros, Roberta A. ;
Fatibello-Filho, Orlando ;
Rocha-Filho, Romeu C. .
CHEMELECTROCHEM, 2020, 7 (06) :1291-1311
[22]   Efficacy and Tolerability of Rifaximin in Combination With Lactulose in End-stage Liver Disease Patients With MELD Greater Than 20: A Single Center Experience [J].
Mantry, P. S. ;
Mehta, A. ;
Graydon, R. .
TRANSPLANTATION PROCEEDINGS, 2014, 46 (10) :3481-3486
[23]   Rifaximin for the Treatment of Hepatic Encephalopathy [J].
Mantry, P. S. ;
Munsaf, S. .
TRANSPLANTATION PROCEEDINGS, 2010, 42 (10) :4543-4547
[24]  
Motta C., 2019, DRUG ANAL RES, V3, P23, DOI [DOI 10.22456/2527-2616.98376, 10.22456/2527-2616.98376]
[25]   Miniaturized Microbiological Method to Determine the Potency of Rifaximin in Tablets [J].
Motta Correa, Clara Bersi ;
Kogawa, Ana Carolina ;
Chorilli, Marlus ;
Nunes Salgado, Herida Regina .
JOURNAL OF AOAC INTERNATIONAL, 2021, 104 (04) :1049-1054
[26]   Rifaximin Is Safe and Well Tolerated for Long-term Maintenance of Remission From Overt Hepatic Encephalopathy [J].
Mullen, Kevin D. ;
Sanyal, Arun J. ;
Bass, Nathan M. ;
Poordad, Fred F. ;
Sheikh, Muhammad Y. ;
Frederick, R. Todd ;
Bortey, Enoch ;
Forbes, William P. .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2014, 12 (08) :1390-+
[27]  
Narendra A., 2013, J DRUG DELIV THER, V3, DOI [10.22270/jddt.v3i2.424, DOI 10.22270/JDDT.V3I2.424]
[28]   A meta-analysis of the use of rifaximin to prevent travellers' diarrhoea [J].
Ng, Qin Xiang ;
Ho, Collin Yih Xian ;
Shin, Dongju ;
Venkatanarayanan, Nandini ;
Chan, Hwei Wuen .
JOURNAL OF TRAVEL MEDICINE, 2017, 24 (05)
[29]   Analysis of pharmaceuticals and biological fluids using modern electroanalytical techniques [J].
Özkan, SA ;
Uslu, B ;
Aboul-Enein, HY .
CRITICAL REVIEWS IN ANALYTICAL CHEMISTRY, 2003, 33 (03) :155-181
[30]  
Patel K.G., 2013, ISRN Analytical Chemistry, V1, DOI DOI 10.1155/2013/613218